<DOC>
	<DOCNO>NCT01485770</DOCNO>
	<brief_summary>This study evaluate safety effectiveness ADX-N05 compare placebo treatment excessive daytime sleepiness adult narcolepsy .</brief_summary>
	<brief_title>A Study Safety Effectiveness ADX-N05 Treatment Excessive Daytime Sleepiness</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<criteria>Diagnosis narcolepsy Good general health Willing able comply study design schedule requirement If female , pregnant lactate Customary bedtime later midnight History significant medical condition , behavioral psychiatric disorder ( include suicidal ideation ) , surgical history Any clinically relevant medical , behavioral psychiatric disorder narcolepsy associate excessive sleepiness History significant cardiovascular disease Body mass index &gt; 34 Excessive caffeine use &gt; 600 mg/day caffeine &gt; 6 cup coffee/day History alcohol drug abuse within past two year Nicotine dependence affect sleep</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>